AbstractThe ubiquitin-proteasome system targets numerous cellular proteins for degradation. In addition, modifications by ubiquitin-like proteins as well as proteins containing ubiquitin-interacting and -associated motifs modulate many others. This tightly controlled process involves multiple specific and general enzymes of the system as well as many modifying and ancillary proteins. Thus, it is not surprising that ubiquitin-mediated degradation/processing/modification regulates a broad array of basic cellular processes. Moreover, aberrations in the system have been implicated, either as a primary cause or secondary consequence, in the pathogenesis of both inherited and acquired neurodegenerative diseases. Recent findings indicate that the ...
Protein accumulation and aggregation with a concomitant loss of proteostasis often con- tribute to n...
© 2016, Springer Science+Business Media New York.Ubiquitin-proteasome system is emerging as an immen...
AbstractAssociation of protein inclusions or aggregates within brain tissues of patients with neurod...
The ubiquitin-proteasome system targets numerous cellular proteins for degradation. In addition, mod...
AbstractThe ubiquitin-proteasome system targets numerous cellular proteins for degradation. In addit...
A shared hallmark for many neurodegenerative disorders is the accumulation of toxic protein species ...
Neurodegenerative disorders are a heterogeneous group of clinically and pathologically diverse disea...
The ubiquitin proteasome system (UPS) is crucial for intracellular protein homeostasis and for degra...
AbstractNeuropathological investigations have identified major hallmarks of chronic neurodegenerativ...
Proteolysis by the ubiquitin-proteasome pathway (UPP) in the nervous system has been extensively stu...
At the cellular level, many neurodegenerative diseases (NDs), often considered proteinopathies, are ...
The accumulation of mutant protein is a common feature of neurodegenerative disease. In Huntington's...
Neurodegenerative diseases are characterised by progressive damage to the nervous system including t...
Over thirty years have passed since the first description of ubiquitin-positive structures in the br...
The accumulation of mutant protein is a common feature of neurodegenerative disease. In Huntington's...
Protein accumulation and aggregation with a concomitant loss of proteostasis often con- tribute to n...
© 2016, Springer Science+Business Media New York.Ubiquitin-proteasome system is emerging as an immen...
AbstractAssociation of protein inclusions or aggregates within brain tissues of patients with neurod...
The ubiquitin-proteasome system targets numerous cellular proteins for degradation. In addition, mod...
AbstractThe ubiquitin-proteasome system targets numerous cellular proteins for degradation. In addit...
A shared hallmark for many neurodegenerative disorders is the accumulation of toxic protein species ...
Neurodegenerative disorders are a heterogeneous group of clinically and pathologically diverse disea...
The ubiquitin proteasome system (UPS) is crucial for intracellular protein homeostasis and for degra...
AbstractNeuropathological investigations have identified major hallmarks of chronic neurodegenerativ...
Proteolysis by the ubiquitin-proteasome pathway (UPP) in the nervous system has been extensively stu...
At the cellular level, many neurodegenerative diseases (NDs), often considered proteinopathies, are ...
The accumulation of mutant protein is a common feature of neurodegenerative disease. In Huntington's...
Neurodegenerative diseases are characterised by progressive damage to the nervous system including t...
Over thirty years have passed since the first description of ubiquitin-positive structures in the br...
The accumulation of mutant protein is a common feature of neurodegenerative disease. In Huntington's...
Protein accumulation and aggregation with a concomitant loss of proteostasis often con- tribute to n...
© 2016, Springer Science+Business Media New York.Ubiquitin-proteasome system is emerging as an immen...
AbstractAssociation of protein inclusions or aggregates within brain tissues of patients with neurod...